Increased RSPO3 expression has been linked to a favorable prognosis in various cancer types, and the introduction of RSPO3 into tumors has been found to mitigate tumor progression [17, 18]. Nevertheless, the precise biological role of RSPO3 in CCA remains uncertain. This evidence concerns the gene RSPO3 and neoplasm.